Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001140361-21-016870
Filing Date
2021-05-12
Accepted
2021-05-11 19:08:05
Documents
7
Effectiveness Date
2021-05-12

Document Format Files

Seq Description Document Type Size
1 S-8 nt10023917x8_s8.htm S-8 76296
2 EXHIBIT 5.1 nt10023917x8_ex5-1.htm EX-5.1 10053
3 EXHIBIT 23.1 nt10023917x8_ex23-1.htm EX-23.1 2597
4 EXHIBIT 23.2 nt10023917x8_ex23-2.htm EX-23.2 2230
5 EXHIBIT 99.2 nt10023917x8_ex99-2.htm EX-99.2 95190
6 nt10023917x8_ex5-1image01.jpg GRAPHIC 9519
7 nt10023917x8_ex23-1image02.jpg GRAPHIC 2218
  Complete submission text file 0001140361-21-016870.txt   203811
Mailing Address 745 FIFTH AVENUE SUITE 1602 NEW YORK NY 10151
Business Address 745 FIFTH AVENUE SUITE 1602 NEW YORK NY 10151 519.322.8800
Tilray, Inc. (Filer) CIK: 0001731348 (see all company filings)

EIN.: 824310622 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-256023 | Film No.: 21912937
SIC: 2833 Medicinal Chemicals & Botanical Products